Terug
Dagbereik
€ 35,64
€ 38,29
52-Weeksbereik
€ 7,26
€ 45,00
Volume
341.100
50D / 200D Gem.
€ 38,16
/
€ 30,86
Vorige Slotkoers
€ 36,39
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (626 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -21,8 | 0,4 |
| P/B | 5,3 | 2,9 |
| ROE % | -105,2 | 3,7 |
| Net Margin % | — | 3,9 |
| Rev Growth 5Y % | — | 10,0 |
| D/E | 0,0 | 0,2 |
Koersdoel Analisten
Hold
€ 46,25
+27.0%
Low: € 24,00
High: € 58,00
Forward WPA
-€ 2,33
Omzet Sch.
0
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
-€ 2,51
-€ 2,51 – -€ 2,51
|
74 M | 5 |
| FY2029 |
-€ 2,78
-€ 2,78 – -€ 2,78
|
33 M | 2 |
| FY2028 |
-€ 3,08
-€ 4,05 – -€ 1,71
|
4,3 M | 7 |
Belangrijkste Punten
Debt/Equity of 0,03 — conservative balance sheet
Negative free cash flow of -66,67M
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-105,18%
ROIC-21,15%
Net MarginN/A
Op. MarginN/A
Veiligheid
Debt / Equity
0,03
Current Ratio20,61
Interest Coverage0,00
Waardering
P/E Ratio
-21,78
P/B Ratio5,34
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0,0 | Net Income (TTM) | -75,27M |
| ROE | -105,18% | ROA | -23,09% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -66,67M |
| ROIC | -21,15% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,03 | Current Ratio | 20,61 |
| Interest Coverage | 0,00 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -21,78 | P/B Ratio | 5,34 |
| P/S Ratio | N/A | PEG Ratio | -0,64 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 1,64B | Enterprise Value | 1,59B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | 0,0 | 0,0 | 0,0 | 0,0 |
| Net Income | -75,27M | -61,69M | -47,26M | -40,24M |
| EPS (Diluted) | -1,88 | -1,40 | -1,07 | -0,91 |
| Gross Profit | -647.000,0 | -668.000,0 | 0,0 | 0,0 |
| Operating Income | -88,98M | -70,56M | -50,33M | -41,37M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Total Assets | 325,95M | 185,75M | 51,95M | 87,37M |
| Total Liabilities | 19,12M | 349,47M | 166,83M | 157,29M |
| Shareholders' Equity | 306,83M | -163,71M | -114,88M | -69,92M |
| Total Debt | 8,68M | 9,75M | 10,48M | 0,0 |
| Cash & Equivalents | 58,45M | 37,79M | 38,52M | 54,84M |
| Current Assets | 241,42M | 150,99M | 39,21M | 83,83M |
| Current Liabilities | 11,71M | 10,42M | 8,04M | 8,25M |